Replimune Group, Inc. (REPL)
10.04
-0.26
(-2.52%)
USD |
NASDAQ |
Dec 10, 13:05
Replimune Group Market Cap: 787.57M for Dec. 10, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Rapt Therapeutics, Inc. | 601.65M |
| Olema Pharmaceuticals, Inc. | 2.003B |
| CorMedix, Inc. | 891.89M |
| Verastem, Inc. | 767.51M |
| Anavex Life Sciences Corp. | 360.97M |
Market Cap Related Metrics
| PEG Ratio | -0.1765 |
| Price to Book Value | 2.991 |
| Price | 10.04 |
| Earnings Yield | -35.93% |
| PEGY Ratio | -0.1765 |